Pfizer Faces Significant Volatility Amid Broader Pharmaceuticals Sector Decline

Pfizer has experienced significant volatility today, reaching a new 52-week low of Rs. 3742.9. The stock has been on a downward trend, losing 5.36% over the past two days, with an opening gap down of 2.36%. Intraday, it touched a low of Rs. 3742.9, reflecting a decline of 6.22%. Currently, Pfizer is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish technical outlook. In the broader market context, the Pharmaceuticals & Drugs sector has also faced challenges, declining by 3.32%. The Sensex, after a significant gap down opening, has shown some recovery but remains 3.51% away from its own 52-week low. Over the past year, Pfizer's performance has been notably poor, with a return of -11.41%, contrasting sharply with the Sensex's decline of only 1.96%. Financially, Pfizer's long-term growth appears limited, with net sales growing at an annual rate of just 0.46% and operating profit at 4.27% over the last five years. The company's recent quarterly results have also shown a decline in profit after tax and net sales, further contributing to its challenging market position.